Evidence map›Paper›PMID 33159016›Full record

ArticleAging2020

Identification of novel

Feng Wang, Shengyu Fu, Jiafan Lei, Hongchen Wu, Shugui Shi, Kangning Chen, Jun Hu, Xueqing Xu

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Aging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Feng WangDepartment of Clinical Laboratory, Shenzhen Baoan Women's and Children's Hospital, Jinan University, Shenzhen, China.
Shengyu FuFaculty of Health Sciences, University of Macau, Taipa, Macau, China.
Jiafan LeiDepartment of Clinical Laboratory, Shenzhen Baoan Women's and Children's Hospital, Jinan University, Shenzhen, China.
Hongchen WuDepartment of Neurology, Chunking General Hospital, Chongqing, China.
Shugui ShiDepartment of Neurology, Chunking General Hospital, Chongqing, China.
Kangning ChenDepartment of Neurology, First Affiliated Hospital of Army Medical University, Army Medical University, Chongqing, China.
Jun HuDepartment of Neurology, First Affiliated Hospital of Army Medical University, Army Medical University, Chongqing, China.
Xueqing XuDepartment of Clinical Laboratory, Shenzhen Baoan Women's and Children's Hospital, Jinan University, Shenzhen, China.
Jinan University · CNUniversity of Macau · MO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by progressive loss of motor neurons. More than 30 genes have been linked to ALS to date, including

Indexed as

AdultAmyotrophic Lateral SclerosisAsian PeopleChinaDNA-Binding ProteinsFemaleHumansMaleMiddle AgedMutationPedigreeRNA-Binding Protein FUSYoung AdultDNA-Binding ProteinsFUS protein, humanRNA-Binding Protein FUSTARDBP protein, humanamyotrophic lateral sclerosisFUSHRM analysisTARDBP

Identifiers

PMID33159016
PMCPMC7746354
OpenAlexW3095525982

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.